These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 3709158)

  • 41. Contact sensitization to 6 alpha-methylprednisolone aceponate.
    Balato N; Patruno C; Lembo G; Cuccurullo FM; Ayala F
    Am J Contact Dermat; 1997 Mar; 8(1):24-5. PubMed ID: 9066844
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Testing with corticosteroid aldehydes in corticosteroid-sensitive patients (preliminary results).
    Matura M; Lepoittevin JP; Arbez-Gindre C; Goossens A
    Contact Dermatitis; 1998 Feb; 38(2):106-8. PubMed ID: 9506226
    [No Abstract]   [Full Text] [Related]  

  • 43. Is tixocortol pivalate a photoallergen?
    Wilkinson SM; Beck MH
    Contact Dermatitis; 1995 Jul; 33(1):55-6. PubMed ID: 7493469
    [No Abstract]   [Full Text] [Related]  

  • 44. Allergic contact dermatitis from topical corticosteroids.
    Rivara G; Tomb RR; Foussereau J
    Contact Dermatitis; 1989 Aug; 21(2):83-91. PubMed ID: 2530056
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Contact allergy for corticosteroids].
    de Groot AC; van Ginkel CJ; Bruynzeel DP
    Ned Tijdschr Geneeskd; 1997 Aug; 141(32):1559-62. PubMed ID: 9543750
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical relevance of tixocortol pivalate-positive patch tests and questionable bioequivalence of different hydrocortisone preparations.
    Shaw DW; Maibach HI
    Contact Dermatitis; 2013 Jun; 68(6):369-75. PubMed ID: 23692037
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Stability of corticosteroid patch test preparations.
    Isaksson M; Gruvberger B; Persson L; Bruze M
    Contact Dermatitis; 2000 Mar; 42(3):144-8. PubMed ID: 10727164
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Recommendation to include budesonide and tixocortol pivalate in the European standard series. ESCD and EECDRG. European Society of Contact Dermatitis.
    Isaksson M; Brandão FM; Bruze M; Goossens A
    Contact Dermatitis; 2000 Jul; 43(1):41-2. PubMed ID: 10902588
    [No Abstract]   [Full Text] [Related]  

  • 49. Reactivity of tixocortol pivalate-positive patients in intradermal and oral provocation tests.
    Räsänen L; Tuomi ML; Ylitalo L
    Br J Dermatol; 1996 Dec; 135(6):931-4. PubMed ID: 8977714
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Contact allergy to hydrocortisone 21-acetate in Italy: A SIDAPA multicenter study.
    Stingeni L; Marietti R; Bianchi L; Ferrucci SM; Foti C; Patruno C; Napolitano M; Gallo R; Corazza M; Schena D; Tramontana M; Hansel K;
    Contact Dermatitis; 2022 Mar; 86(3):217-219. PubMed ID: 34726778
    [No Abstract]   [Full Text] [Related]  

  • 51. Topical corticosteroid allergy in an urban Australian centre.
    Keegel T; Saunders H; Milne R; Sajjachareonpong P; Fletcher A; Nixon R
    Contact Dermatitis; 2004 Jan; 50(1):6-14. PubMed ID: 15059096
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Corticosteroid or steroid allergy?
    Schoenmakers A; Vermorken A; Degreef H; Dooms-Goossens A
    Contact Dermatitis; 1992 Mar; 26(3):159-62. PubMed ID: 1505180
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tixocortol pivalate: what is the right concentration?
    Kalavala M; Statham BN; Green CM; King C; Ormerod AD; Sansom J; English JS; Wilkinson MS; Horne H; Gawkrodger D
    Contact Dermatitis; 2007 Jul; 57(1):44-6. PubMed ID: 17577357
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Results of patch testing with hydrocortisone butyrate in different vehicles.
    Wilkinson SM; Beck MH; Steel I
    Contact Dermatitis; 2000 May; 42(5):299-300. PubMed ID: 10789860
    [No Abstract]   [Full Text] [Related]  

  • 55. Tixocortol pivalate contact allergy in the GPMT: frequency and cross-reactivity.
    Frankild S; Lepoittevin JP; Kreilgaard B; Andersen KE
    Contact Dermatitis; 2001 Jan; 44(1):18-22. PubMed ID: 11156006
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Results of routine patch testing with corticosteroid series in 2073 patients.
    Dooms-Goossens A; Morren M
    Contact Dermatitis; 1992 Mar; 26(3):182-91. PubMed ID: 1505184
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Are the Spanish baseline series markers sufficient to detect contact allergy to corticosteroids in Spain? A GEIDAC prospective study.
    Mercader-García P; Pastor-Nieto MA; García-Doval I; Giménez-Arnau A; González-Pérez R; Fernández-Redondo V; Serra-Baldrich E; Cordoba-Guijarro S; Gatica-Ortega ME; Silvestre-Salvador JF;
    Contact Dermatitis; 2018 Jan; 78(1):76-82. PubMed ID: 28960334
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Contribution to corticosteroid allergy].
    Esser B
    Z Hautkr; 1983 Jan; 58(1):29-32. PubMed ID: 6219504
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The significance of tixocortol-pivalate-positive patch tests in leg ulcer patients.
    Wilkinson M; Cartwright P; English JS
    Contact Dermatitis; 1990 Aug; 23(2):120-1. PubMed ID: 2145125
    [No Abstract]   [Full Text] [Related]  

  • 60. Hydrocortisone sensitivity: clinical features of fifty-nine cases.
    Wilkinson SM; English JS
    J Am Acad Dermatol; 1992 Nov; 27(5 Pt 1):683-7. PubMed ID: 1430387
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.